For research use only — not for human or veterinary use

Buy 2 vials, get bacteriostatic water free

Tirzepatide

Weight Loss

Tirzepatide

Dual GIP/GLP-1 receptor agonist for metabolic research

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist studied for metabolic effects.

Select a size

1

Line total

$99.00

Picked and packed within 48 hours of cleared payment, Monday to Friday.

No account needed — checkout takes about a minute. A free 30 mL bacteriostatic water vial comes with every 2 vials, and standard cold-chain shipping is free over $150.

Subscribe & save time

Have this compound delivered on a recurring schedule. You're billed each cycle and can pause, resume or change the timing yourself from your subscription page.

Per-cycle subtotal
$99.00
Per-cycle shipping
$5.99
Billed each cycle
$104.99

Pause, resume or change the schedule anytime from My subscriptions.

Specifications

Purity
>99% (HPLC)
Form
Lyophilized powder
Sequence
Available on request
Molecular weight
≈ 4,813.5 Da
CAS number
2023788-19-2
Storage
Store at -20°C

Specifications are listed for reference. Always confirm against the certificate of analysis supplied with your lot.

Research context

Tirzepatide is studied for synergistic GIP and GLP-1 receptor activation in metabolic models.

Research use only

This material is supplied for in-vitro laboratory research and analytical study only. It is not for human or veterinary use, not a medicine, supplement or cosmetic, and must never be ingested, injected or applied to any living organism. Purchasers must be 21 or over and qualified to handle research chemicals safely.

Research & literature

What published research reports

The following summarises peer-reviewed literature for scientific reference only. AethelBio products are supplied strictly for in-vitro laboratory research and are not intended for human or veterinary use, diagnosis, prevention, or treatment of any condition.

Proposed mechanism

Dual agonism of GIP and GLP-1 receptors for enhanced glucose control and reduced appetite.

Reported areas of research

Studies report improved glycemic and weight endpoints in animal models. Preclinical only.

Scientific papers on PubMed

Links open the U.S. National Library of Medicine's PubMed database. AethelBio does not host or endorse the listed studies; they are provided for researchers to review primary sources directly.

Researchers also study

Compounds often paired with Tirzepatide

Other peptides studied in the same research areas, selected from the catalog by shared application.

Verified buyer reviews

What researchers say

Reviews come from verified buyers — the first appear as researchers share their results.